Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
3.040
-3.730 (-55.10%)
At close: Jul 7, 2025, 4:00 PM
3.080
+0.040 (1.32%)
Pre-market: Jul 8, 2025, 5:50 AM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $45.67 million as of July 8, 2025. Its market cap has decreased by -86.95% in one year.
Market Cap
45.67M
Enterprise Value
-541.75K
1-Year Change
-86.95%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $45.67M, a decrease of -62.80%. That is a compound annual growth rate of -16.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 45.67M | -85.76% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.83B |
| Johnson & Johnson | 373.59B |
| AbbVie | 331.43B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 275.51B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.62B |
| AstraZeneca | 216.19B |